Michael E Rome's Net Worth

$0

Estimate Recalculated Apr 15, 2024 05:28PM EST

Who is Michael E Rome?

Michael E Rome does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include FS Development Corp. II, Theseus Pharmaceuticals, Inc., Kinnate Biopharma Inc., and FS Development Corp..

SEC CIK

Michael E Rome's CIK is 0001820818

Past Insider Trading and Trends

2020 was Michael E Rome's most active year for acquiring shares with 1 total transactions. Michael E Rome's most active month to acquire stocks was the month of May. 2020 saw Michael E Rome paying a total of $0.00 for 40,501 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

FS Development Corp. II No price found

Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

Kinnate Biopharma Inc. (KNTE) Snapshot price: $2.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 3
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found

FS Development Corp. (IRON) Snapshot price: $65.37

Vice President

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found